IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

SEC filing

IOVANCE BIOTHERAPEUTICS, INC.

IOVA · CIK 1425205

4 · Sep 10, 2026 · Chief Operating Officer BILINSKY IGOR exercised options for 7,813 shares; reported 3,976 shares

Chief Operating Officer BILINSKY IGOR exercised options for 7,813 shares; reported 3,976 shares

OWNERSHIP DOCUMENT

xslF345X06/tm2625111-2_4seq1.xmlSEC.gov

Graphics and non-inline formats (not embedded below).